BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Limosilactobacillus fermentum {L. fermentum} - Escherichia |
👪
Bacteriocins produced by L. Fermentum and L. Acidophilus can inhibit cephalosporin resistant e. Coli. Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: 41 Issue 3 Pages: 643-8 Pub: 2010 Jul Epub: 2010 Sep 1 Authors Riaz S , Kashif Nawaz S , Hasnain S , Html Article Publication |
| Limosilactobacillus fermentum {L. fermentum} - Escherichia |
👶
Probiotic-Loaded Bacterial Cellulose as an Alternative to Combat Carbapenem-Resistant Bacterial Infections. Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 13 Issue 11 Pages: Pub: 2024 Oct 25 Epub: 2024 Oct 25 Authors Gutiérrez-Fernández J , Cerezo-Collado L , Garcés V , Alarcón-Guijo P , Delgado-López JM , Dominguez-Vera JM , Html Article Publication |
| Limosilactobacillus fermentum {L. fermentum} - Escherichia |
👪
Harnessing the probiotic properties and immunomodulatory effects of fermented food-derived Limosilactobacillus fermentum strains: implications for environmental enteropathy. Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1200926 Pub: 2023 Epub: 2023 Jun 5 Authors Prakash V , Madhavan A , Veedu AP , Babu P , Jothish A , Nair SS , Suhail A , Prabhakar M , Sain T , Rajan R , Somanathan P , Abhinand K , Nair BG , Pal S , Html Article Publication |
| Limosilactobacillus fermentum {L. fermentum} - Escherichia |
👪
In vivo safety assessment of Lactobacillus fermentum strains, evaluation of their cholesterol-lowering ability and intestinal microbial modulation. Journal of the science of food and agriculture (J Sci Food Agric ) Vol: 100 Issue 2 Pages: 705-713 Pub: 2020 Jan 30 Epub: 2019 Nov 9 Authors Thumu SCR , Halami PM , Publication |
| Limosilactobacillus fermentum {L. fermentum} - Escherichia |
👶
Lactobacillus fermentum and Lactobacillus plantarum increased gut microbiota diversity and functionality, and mitigated Enterobacteriaceae, in a mouse model. Beneficial microbes (Benef Microbes ) Vol: 10 Issue 4 Pages: 413-424 Pub: 2019 Apr 19 Epub: 2019 Apr 8 Authors Linninge C , Xu J , Bahl MI , Ahrné S , Molin G , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
